CN1799614A - Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof - Google Patents
Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof Download PDFInfo
- Publication number
- CN1799614A CN1799614A CN 200510114732 CN200510114732A CN1799614A CN 1799614 A CN1799614 A CN 1799614A CN 200510114732 CN200510114732 CN 200510114732 CN 200510114732 A CN200510114732 A CN 200510114732A CN 1799614 A CN1799614 A CN 1799614A
- Authority
- CN
- China
- Prior art keywords
- radix
- semen
- cortex
- preparation
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention provides a Chinese medicinal composition for treating liver and kidney diseases and its preparing method, wherein the composition is prepared from the following raw materials (by weight portions): dried rehamnnia root 10-30, wofberry bark 6-15, fleece-flower root 10-30, coix seed 10-30, atractylodes rhizome 5-15, radix salvia miltiorrhiza 5-15, rhizome of Sichuan lovage 3-10, wild or spiny jujuba seed 10-20, bark of peony root 6-15, pubescent angelica root 5-15, cortex acanthopanacis 5-15, peach kernel 5-10, and licorice root 3-10, Chinese angelica root 5-15, radix scrophulariae 10-15, dahurian angelica root 3-10, banksia rose 3-10 and evodia rutaecarpa 1.5-6.
Description
Technical field
Part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels pellet) and preparation method thereof the present invention relates to a kind of Chinese medicine composition for the treatment of liver, kidney disease (is called for short:.
Background technology
Liver, kidney disease are common many diseases, cause people's metabolism disorder easily, and the medicine for the treatment of liver, kidney disease at present has a lot, but has following problems, and curative effect is not remarkable, or has toxic and side effects.
Summary of the invention
Part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels pellet) and preparation method thereof purpose of the present invention provides a kind of Chinese medicine composition for the treatment of liver, kidney disease (to be called for short:, overcome the shortcoming of above-mentioned medicine.
The objective of the invention is to be achieved through the following technical solutions:
A kind of Chinese medicine composition for the treatment of liver, kidney disease provided by the invention is by the preparation that comprises that following weight portion raw material components is prepared from:
Radix Rehmanniae 10-30 Cortex Lycii 6-15
Radix Polygoni Multiflori 10-30 Semen Coicis 10-30
Rhizoma Atractylodis 5-15 Radix Salviae Miltiorrhizae 5-15
Rhizoma Chuanxiong 3-10 Semen Ziziphi Spinosae 10-20
Cortex Moutan 6-15 Radix Angelicae Pubescentis 5-15
Cortex Acanthopancis 5-15 Semen Persicae 5-10
Radix Glycyrrhizae 3-10 Radix Angelicae Sinensis 5-15
Radix Scrophulariae 10-15 Radix Angelicae Dahuricae 3-10
Radix Aucklandiae 3-10 Fructus Evodiae 1.5-6.
Described raw material is preferably following parts by weight of component:
Radix Rehmanniae 10 Cortex Lycii 6
Radix Polygoni Multiflori 10 Semen Coiciss 10
Rhizoma Atractylodis 5 Radix Salviae Miltiorrhizaes 5
Rhizoma Chuanxiong 3 Semen Ziziphi Spinosaes 10
Cortex Moutan 6 Radix Angelicae Pubescentiss 5
Cortex Acanthopancis 5 Semen Persicaes 5
Radix Glycyrrhizae 3 Radix Angelicae Sinensis 5
Radix Scrophulariae 10 Radixs Angelicae Dahuricae 3
The Radix Aucklandiae 3 Fructus Evodiaes 1.5;
Or be preferably:
Radix Rehmanniae 20 Cortex Lycii 10
Radix Polygoni Multiflori 20 Semen Coiciss 20
Rhizoma Atractylodis 10 Radix Salviae Miltiorrhizaes 10
Rhizoma Chuanxiong 7 Semen Ziziphi Spinosaes 15
Cortex Moutan 10 Radix Angelicae Pubescentiss 10
Cortex Acanthopancis 10 Semen Persicaes 7
Radix Glycyrrhizae 7 Radix Angelicae Sinensis 10
Radix Scrophulariae 12 Radixs Angelicae Dahuricae 6
The Radix Aucklandiae 7 Fructus Evodiaes 4.
Described preparation can be made into multiple pharmaceutical preparation, is preferably pill, tablet, capsule.
The present invention also provides a kind of preparation method for the treatment of the Chinese medicine composition of liver, kidney disease, may further comprise the steps: get above-mentioned raw materials, mix, pulverize, make pharmaceutical preparation then routinely.
Described pulverizing is meant that preferred powder is broken to 420 order powder; Described preparation is pill, tablet, capsule.
The function that the present invention treats the Chinese medicine composition (part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels pellet) of liver, kidney disease cures mainly: cure mainly nephritis, can treat also that hepatitis, costalgia, soreness of the waist and knees, impotence and premature ejaculation, cramp, lower limb swell and ache, deaf, refreshing disease disease such as tired.
The present invention treats Chinese medicine composition (part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels pellet) instructions of taking of liver, kidney disease: three times on the one, and each 4 grams, seven is a course of treatment.
The present invention has the following advantages;
1, evident in efficacy, long-term clinic trial, the cure rate height has no side effect.
2, preparation method is simple, has reduced cost, and raw material sources conveniently are easy to get, and is with low cost.Be the curative effect of proof medicine of the present invention, the inventor has carried out the treatment liver of following embodiment 1, the Chinese medicine composition of kidney disease (is called for short: clinical trial part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels pellet).
One, case history source and typical analysis of medical record:
Case source: from 1996 to 2004 in the period of, observation can be added up case 226 examples, wherein male 156 examples, women 70 examples, the oldest person 68 years old, reckling 6 years old, course of disease elder reaches 20 years, weak point person 6 months.
Instructions of taking: red, pill, three times on the one, each 4 grams, seven is a course of treatment.
Two, curative effect determinate standard:
Cure: various metabolism disorders recover normally fully, clinical symptom disappearance, clinical biochemical index ideal.
Effectively: clinical symptoms is clearly better, and various metabolism disorders obviously improve, and the clinical biochemical index is more satisfactory.
Invalid: clinical symptoms is not improved, and various metabolism disorders do not have change, do not reach " effectively " standard, and the clinical biochemical index is undesirable.
Three, observation of curative effect result:
To the secular observation of curative effect of burnt card patient in 226 examples, the result cures patient's 217 examples, effective patient's 5 examples, and invalid patient's 4 examples, accounting for its total percentage ratio respectively is 96.02%, 2.21%, 1.77%.
Sum up:
The main component of medicine of the present invention has 18 flavor Chinese crude drugs such as Radix Polygoni Multiflori, Radix Scrophulariae, Radix Angelicae Sinensis; Show that through clinical observation its total cure rate reaches 96.02%; This medicine has no side effect, and cost is low, taking convenience.
The specific embodiment
Embodiment 1
A kind of Chinese medicine composition for the treatment of liver, kidney disease (is called for short: part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels pellet): sublimed preparation or pill
Get following raw material (kg): Radix Rehmanniae 10, Cortex Lycii 6, Radix Polygoni Multiflori 10, Semen Coicis 10, Rhizoma Atractylodis 5, Radix Salviae Miltiorrhizae 5, Rhizoma Chuanxiong 3, Semen Ziziphi Spinosae 10, Cortex Moutan 6, Radix Angelicae Pubescentis 5, Cortex Acanthopancis 5, Semen Persicae 5, Radix Glycyrrhizae 3, Radix Angelicae Sinensis 5, Radix Scrophulariae 10, the Radix Angelicae Dahuricae 3, the Radix Aucklandiae 3, Fructus Evodiae 1.5.
Preparation method: get above-mentioned raw materials, mix, be crushed to 420 order powder, make sublimed preparation or pill then according to a conventional method.
Embodiment 2
A kind of Chinese medicine composition for the treatment of liver, kidney disease: capsule
Get following raw material (kg): Radix Rehmanniae 20, Cortex Lycii 10, Radix Polygoni Multiflori 20, Semen Coicis 20, Rhizoma Atractylodis 10, Radix Salviae Miltiorrhizae 10, Rhizoma Chuanxiong 7, Semen Ziziphi Spinosae 15, Cortex Moutan 10, Radix Angelicae Pubescentis 10, Cortex Acanthopancis 10 Semen Persicaes 7, Radix Glycyrrhizae 7, Radix Angelicae Sinensis 10, Radix Scrophulariae 12, the Radix Angelicae Dahuricae 6, the Radix Aucklandiae 7, Fructus Evodiae 4.
Preparation method: get above-mentioned raw materials, mix, be crushed to 100 orders, make capsule then according to a conventional method.
Embodiment 3
A kind of Chinese medicine composition for the treatment of liver, kidney disease: tablet
Get following raw material (kg): Fructus Crataegi 5, Fructus Gardeniae 3, Pericarpium Citri Reticulatae 3, Radix Codonopsis 10, Radix Scutellariae 3, Cortex Phellodendri 5, the Rhizoma Atractylodis Macrocephalae 10, Rhizoma Alismatis 5, Ramulus Cinnamomi 3, the Cortex Eucommiae 10, Radix Glycyrrhizae 3, Semen Armeniacae Amarum 5, Poria 10.
Preparation method: get above-mentioned raw materials, mix, be crushed to 200 orders, add magnesium stearate 0.5kg, make tablet then according to a conventional method.
Claims (5)
1, a kind of Chinese medicine composition for the treatment of liver, kidney disease is by the preparation that comprises that following weight portion raw material components is prepared from:
Radix Rehmanniae 10-30 Cortex Lycii 6-15
Radix Polygoni Multiflori 10-30 Semen Coicis 10-30
Rhizoma Atractylodis 5-15 Radix Salviae Miltiorrhizae 5-15
Rhizoma Chuanxiong 3-10 Semen Ziziphi Spinosae 10-20
Cortex Moutan 6-15 Radix Angelicae Pubescentis 5-15
Cortex Acanthopancis 5-15 Semen Persicae 5-10
Radix Glycyrrhizae 3-10 Radix Angelicae Sinensis 5-15
Radix Scrophulariae 10-15 Radix Angelicae Dahuricae 3-10
Radix Aucklandiae 3-10 Fructus Evodiae 1.5-6.
2, according to the treatment liver of claim 1, the Chinese medicine composition of kidney disease, described raw material is following parts by weight of component:
Radix Rehmanniae 10 Cortex Lycii 6
Radix Polygoni Multiflori 10 Semen Coiciss 10
Rhizoma Atractylodis 5 Radix Salviae Miltiorrhizaes 5
Rhizoma Chuanxiong 3 Semen Ziziphi Spinosaes 10
Cortex Moutan 6 Radix Angelicae Pubescentiss 5
Cortex Acanthopancis 5 Semen Persicaes 5
Radix Glycyrrhizae 3 Radix Angelicae Sinensis 5
Radix Scrophulariae 10 Radixs Angelicae Dahuricae 3
The Radix Aucklandiae 3 Fructus Evodiaes 1.5;
Or:
Radix Rehmanniae 20 Cortex Lycii 10
Radix Polygoni Multiflori 20 Semen Coiciss 20
Rhizoma Atractylodis 10 Radix Salviae Miltiorrhizaes 10
Rhizoma Chuanxiong 7 Semen Ziziphi Spinosaes 15
Cortex Moutan 10 Radix Angelicae Pubescentiss 10
Cortex Acanthopancis 10 Semen Persicaes 7
Radix Glycyrrhizae 7 Radix Angelicae Sinensis 10
Radix Scrophulariae 12 Radixs Angelicae Dahuricae 6
The Radix Aucklandiae 7 Fructus Evodiaes 4.
3, according to the treatment liver of claim 1 or 2, the Chinese medicine composition of kidney disease, described preparation is pill, tablet, capsule.
4, a kind of preparation method for the treatment of the Chinese medicine composition of liver, kidney disease, may further comprise the steps: the weighting profit requires Radix Rehmanniae, Cortex Lycii, Radix Polygoni Multiflori, Semen Coicis, Rhizoma Atractylodis, Radix Salviae Miltiorrhizae, cnidium acid Semen Ziziphi Spinosae, Cortex Moutan, Radix Angelicae Pubescentis, Cortex Acanthopancis, Semen Persicae, Radix Glycyrrhizae, Radix Angelicae Sinensis, Radix Scrophulariae, the Radix Angelicae Dahuricae, the Radix Aucklandiae, the Fructus Evodiae of one of 1-2, mix, pulverize, make pharmaceutical preparation then routinely.
5, according to the preparation of drug combination method of the treatment cardiovascular and cerebrovascular disease of claim 4, described pulverizing is meant and is crushed to 420 order powder; Described preparation is pill, tablet, capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101147324A CN100377737C (en) | 2005-10-26 | 2005-10-26 | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101147324A CN100377737C (en) | 2005-10-26 | 2005-10-26 | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1799614A true CN1799614A (en) | 2006-07-12 |
| CN100377737C CN100377737C (en) | 2008-04-02 |
Family
ID=36809973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101147324A Expired - Fee Related CN100377737C (en) | 2005-10-26 | 2005-10-26 | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100377737C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922489A (en) * | 2015-07-17 | 2015-09-23 | 江苏苏南药业实业有限公司 | Traditional Chinese medicine composition for treating chronic nephritis and preparation method thereof |
| CN105648500A (en) * | 2014-11-28 | 2016-06-08 | 堀金属表面处理工业股份有限公司 | Manufacturing method of product made of magnesium or magnesium alloy |
| CN105648501A (en) * | 2014-11-28 | 2016-06-08 | 堀金属表面处理工业股份有限公司 | Manufacturing method of product composed of magnesium or magnesium alloy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1062157C (en) * | 1996-11-30 | 2001-02-21 | 李泽良 | Hepatitis B curing toxin-dissipating pill |
| CN1171601C (en) * | 2001-07-16 | 2004-10-20 | 夏伍明 | Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process |
| CN1120013C (en) * | 2001-08-15 | 2003-09-03 | 沙鹏程 | Medicine for nourishing liver, kidney and hair and beautifying face and its preparing process |
| CN1233382C (en) * | 2002-12-24 | 2005-12-28 | 潘小红 | Chinese medicine 'Shentiansu' for internal organ diseases |
-
2005
- 2005-10-26 CN CNB2005101147324A patent/CN100377737C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105648500A (en) * | 2014-11-28 | 2016-06-08 | 堀金属表面处理工业股份有限公司 | Manufacturing method of product made of magnesium or magnesium alloy |
| CN105648501A (en) * | 2014-11-28 | 2016-06-08 | 堀金属表面处理工业股份有限公司 | Manufacturing method of product composed of magnesium or magnesium alloy |
| CN104922489A (en) * | 2015-07-17 | 2015-09-23 | 江苏苏南药业实业有限公司 | Traditional Chinese medicine composition for treating chronic nephritis and preparation method thereof |
| CN104922489B (en) * | 2015-07-17 | 2018-06-01 | 江苏苏南药业实业有限公司 | A kind of Chinese medicine composition for treating chronic nephritis and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100377737C (en) | 2008-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN101987123B (en) | Medicament for easing pain of human body and preparation method thereof | |
| CN101987122B (en) | Medicament for easing pain of human body and preparation method thereof | |
| CN102178850B (en) | Medicament for treating headache | |
| CN101632737A (en) | Medicament for relieving pain of human body and preparation method thereof | |
| CN112891399A (en) | Traditional Chinese medicine composition and application and preparation method thereof | |
| CN1175456A (en) | Traditional Chinese medicine composition for treatment of female dysgenesis | |
| CN1799614A (en) | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof | |
| CN1966067A (en) | Medicament for treating aplastic anemia | |
| CN1539441A (en) | Compounded medicine for anti pathogeny and immunoenhancement | |
| CN1806834A (en) | Chinese medicine for treating AIDS | |
| CN1245173C (en) | Medicine composition for treating liver fibrillation and liver cirrhosis and its prepn process | |
| CN1223374C (en) | Chinese medicinal composition for treating hepatitis B | |
| CN1490017A (en) | Medicines against rheunatoid and rheumatic diseases | |
| CN1298362C (en) | Compound Chinese medicine prepn for treating pulvic infection and its prepn process | |
| CN1785391A (en) | Chinese medicinal composition and its preparation method | |
| CN1141784A (en) | Anti-cancer medicine and preparation method thereof | |
| CN1111046C (en) | Chinese medicine preparation for curing postpartum disease of woman | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1709288A (en) | Medicinal composition, and its preparing method and use | |
| CN1242767C (en) | Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method | |
| CN1799598A (en) | Chinese medicinal composition for treating spleen and stomach diseases and preparation method thereof | |
| CN111407860A (en) | A Chinese medicinal composition for treating dementia and preparation method thereof | |
| CN101278982A (en) | Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same | |
| CN1136939A (en) | Chinese drugs for curing hepatitis B |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080402 Termination date: 20161026 |